On May 28, 2024, Omega Therapeutics, Inc. (company) and Yan Moore, M.D., the company?s Chief Medical Officer, agreed to terminate his employment effective as of May 31, 2024. In connection with the termination, Dr. Moore entered into a separation agreement with the Company containing a release of claims that provides for the severance payments and benefits set forth in his employment agreement with the Company.